By Canadian Press

Health Canada authorizes updated Novavax COVID-19 vaccine targeting XBB variant

Dec 5, 2023 | 1:45 PM

OTTAWA — Health Canada has authorized an updated COVID-19 vaccine from Novavax that targets the XBB.1.5 variant. 

The new vaccine is called Nuvaxovid and is approved for people 12 years of age and over. 

Nuvaxovid is a protein subunit vaccine, meaning it contains harmless pieces of virus. 

The other two XBB vaccines currently authorized in Canada are mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna.

The mRNA options remain the only XBB vaccines approved for children under 12. 

to speak at upcoming conference

Former Red Deerian shares recovery journey from drugs and crime, suggests possible solutions

22h ago

judicial review to continue in june

Day 3 of LaGrange v. Red Deer Catholic: The meme had, "nothing to do with the Holocaust"

May 03, 2024

April 2023 Incident

Two-year prison term for man convicted in arson fire of Red Deer Canadian Tire store

May 03, 2024

The National Advisory Committee on Immunization recommends that everyone six months of age and older get the XBB.1.5 vaccine if it has been six months or longer since their last COVID-19 vaccination or COVID-19 infection.  

This report by The Canadian Press was first published Nov. 5, 2023.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press